Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial

Lancet

Volumn 357, Issue 9262, 2001, Pages 1076-1079

  Kalliomäki, Marko ^a   Salminen, Seppo ^a   Arvilommi, Heikki ^b   Kero, Pentti ^a   Koskinen, Pertti ^a   Isolauri, Erika ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECZEMA; FEMALE; HUMAN; INFANT; INTESTINE FLORA; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRENATAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

LACTOBACILLUS;

EID: 0035820307     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04259-8     Document Type: Article

References (39)

1. The epidemic of allergy and asthma
2. Prevalence of asthma symptoms in video and written questionnaires among children in four regions of Finland
3. Prevalence of allergic rhinitis and atopic dermatitis among children in four regions of Finland
4. Hay fever, hygiene, and household size
5. Measles and atopy in Guinea-Bissau
6. The inverse association between tuberculin responses and atopic disorder
7. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: Epidemiological study
8. Measles history and atopic diseases: A population-based cross-sectional study
9. Role of microbial burden in aetiology of allergy and asthma
10. Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TGF-beta) by human colonic epithelial cells
11. Probiotics in the management of atopic eczema
12. CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation
13. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction
14. Immunological aspects of host/microbiota interactions at the intestinal epithelium
15. Functional food science and gastrointestinal physiology and function
16. Probiotics: A novel approach in the management of food allergy
17. Atopic dermatitis
18. Severity scoring of atopic dermatitis: The SCORAD index. Consensus report of the European Task Force on atopic dermatitis
19. Asthma: A follow-up statement from an international paediatric asthma consensus group
20. Transforming growth factor-β in breast milk: A potential regulator of atopic disease at an early age
21. The number needed to treat: A clinically useful measure of treatment effect
22. Confidence intervals rather than P values: Estimation rather than hypothesis testing
23. Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease
24. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats
25. Evaluation of the gut mucosal barrier: Evidence for increased antigen transfer in children with atopic eczema
26. Local immune response in patients with cow milk allergy: Follow-up of patients retaining allergy or becoming tolerant
27. The intestinal microflora in allergic Estonian and Swedish 2-year-old children
28. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells
29. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG
30. Decreased atopy in children infected with Schistosoma haematobium: A role for parasite-induced interleukin-10
31. Development of allergen-specific T-cell memory in atopic and normal children
32. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing
33. The influence of dietary protein antigen on Th1/Th2 balance and cellular immunity
34. Probiotics reinforce mucosal degradation of antigens in rats: Implications for therapeutic use of probiotics
35. Abrogation of oral tolerance by feeding encapsulated antigen
36. Serum IgE levels during the first 6 years of life
37. Natural course of sensitization to food and inhalant allergens during the first 6 years of life
38. Atopic diseases in infancy: The German multicenter atopy study (MAS-90)
39. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years